CompletedNot Applicable

REnal reCOVery After ECMO for Cardiogenic Shock (RECOVECMO)

France93 participantsStarted 2022-01-01

Plain-language summary

This retrospective study assesses long term renal outcome in patients having suffered medical or post cardiotomy refractory cardiogenic shock requiring renal replacement therapy (RRT) concomitant with veno-arterial extracorporeal membrane oxygenation (VA-ECMO). The authors seek to establish for accurate definition of renal recovery status predicting poor long-term renal outcomes.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients over 18 years old * Medical or post cardiotomy refractory cardiogenic shock * Patients requiring concomitant renal replacement therapy (RRT) and venoarterial extracorporeal membrane oxygenation (VA-ECMO) Exclusion Criteria: * Congenital heart diseases * Severe pre operative chronic kidney disease (eGFR \< 30ml/min/1,73m2) * Death within the first 7 days of ECMO * Patient receiving non-concomitant ECMO and RRT

What they're measuring

Complete renal recovery status according first definition

Timeframe: 90 days from AKI (acute Kidney Injury) start

Complete renal recovery status according second definition

Timeframe: 90 days from AKI start

Long term renal outcome

Timeframe: 2 years from AKI start

Trial details

NCT IDNCT05788211

SponsorUniversity Hospital, Bordeaux

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-04-01

View on ClinicalTrials.gov More Cardiogenic Shock trials